TRIM37

Defactinib: A first‑in‑Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS‑6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors

PF 429242 : Subtilisin of Leishmania amazonensis as Potential Druggable Target: Subcellular Localization, In Vitro Leishmanicidal Activity and Molecular Docking of PF-429242, a Subtilisin Inhibitor

MRTX1133 : A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer